Hala B AlEssa1, Vasanti S Malik1, Changzheng Yuan1, Walter C Willett1,2,3, Tianyi Huang2,3, Frank B Hu1,2,3, Deirdre K Tobias4,5. 1. Departments of Nutrition and. 2. Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA; and. 3. Channing Division of Network Medicine, Department of Medicine, and. 4. Departments of Nutrition and dtobias@partners.org. 5. Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Abstract
BACKGROUND: Healthful dietary patterns have been associated with lower risks of type 2 diabetes and coronary artery disease, but their relations with intermediate markers of cardiometabolic and endocrine health are less established. OBJECTIVE: We evaluated the Dietary Approaches to Stop Hypertension (DASH), the alternate Mediterranean diet (aMED), and the Alternate Healthy Eating Index (aHEI) diet-quality scores with cardiometabolic and endocrine plasma biomarkers in US women. DESIGN: The trial was a cross-sectional analysis of 775 healthy women in the Women's Lifestyle Validation Study that was conducted within the NHS (Nurses' Health Study) and NHS II longitudinal cohorts. Multiple linear regression models adjusted for potential confounders were used to estimate associations between quartiles of dietary pattern-adherence scores that were derived from a food-frequency questionnaire and plasma biomarker concentrations that were collected simultaneously. RESULTS: In multivariable models in which highest and lowest quartiles of dietary pattern scores were compared, 1) DASH was significantly associated with higher concentrations of high-density lipoprotein (9%) and sex-hormone binding globulin (SHBG) (21%), and lower concentrations of leptin (28%), triglycerides (19%), and C-peptide (4%) (all P-trend ≤ 0.04); 2) the aMED was associated with 19% higher SHBG and 16% lower triglycerides (P-trend = 0.02 and 0.003, respectively); and 3) the aHEI was associated with significantly higher concentrations of insulin (16%) and SHBG (19%) and lower concentrations of leptin (18%) (all P-trend ≤ 0.02). Further adjustment for body mass index (BMI) attenuated these associations but remained significant for 1) DASH with leptin and triglycerides and 2) the aMED with triglycerides (all P-trend ≤ 0.03). CONCLUSIONS: Adherence to healthful dietary patterns is associated with favorable concentrations of many cardiometabolic and endocrine biomarkers. These relations are mediated in part by BMI.
BACKGROUND: Healthful dietary patterns have been associated with lower risks of type 2 diabetes and coronary artery disease, but their relations with intermediate markers of cardiometabolic and endocrine health are less established. OBJECTIVE: We evaluated the Dietary Approaches to Stop Hypertension (DASH), the alternate Mediterranean diet (aMED), and the Alternate Healthy Eating Index (aHEI) diet-quality scores with cardiometabolic and endocrine plasma biomarkers in US women. DESIGN: The trial was a cross-sectional analysis of 775 healthy women in the Women's Lifestyle Validation Study that was conducted within the NHS (Nurses' Health Study) and NHS II longitudinal cohorts. Multiple linear regression models adjusted for potential confounders were used to estimate associations between quartiles of dietary pattern-adherence scores that were derived from a food-frequency questionnaire and plasma biomarker concentrations that were collected simultaneously. RESULTS: In multivariable models in which highest and lowest quartiles of dietary pattern scores were compared, 1) DASH was significantly associated with higher concentrations of high-density lipoprotein (9%) and sex-hormone binding globulin (SHBG) (21%), and lower concentrations of leptin (28%), triglycerides (19%), and C-peptide (4%) (all P-trend ≤ 0.04); 2) the aMED was associated with 19% higher SHBG and 16% lower triglycerides (P-trend = 0.02 and 0.003, respectively); and 3) the aHEI was associated with significantly higher concentrations of insulin (16%) and SHBG (19%) and lower concentrations of leptin (18%) (all P-trend ≤ 0.02). Further adjustment for body mass index (BMI) attenuated these associations but remained significant for 1) DASH with leptin and triglycerides and 2) the aMED with triglycerides (all P-trend ≤ 0.03). CONCLUSIONS: Adherence to healthful dietary patterns is associated with favorable concentrations of many cardiometabolic and endocrine biomarkers. These relations are mediated in part by BMI.
Authors: Teresa T Fung; Frank B Hu; Marjorie L McCullough; P K Newby; Walter C Willett; Michelle D Holmes Journal: J Nutr Date: 2006-02 Impact factor: 4.798
Authors: Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González Journal: N Engl J Med Date: 2013-02-25 Impact factor: 91.245
Authors: Eunyoung Cho; Wendy Y Chen; David J Hunter; Meir J Stampfer; Graham A Colditz; Susan E Hankinson; Walter C Willett Journal: Arch Intern Med Date: 2006-11-13
Authors: W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1985-07 Impact factor: 4.897
Authors: S Salvini; D J Hunter; L Sampson; M J Stampfer; G A Colditz; B Rosner; W C Willett Journal: Int J Epidemiol Date: 1989-12 Impact factor: 7.196
Authors: Yanan Ma; Wanshui Yang; Tracey G Simon; Stephanie A Smith-Warner; Teresa T Fung; Jing Sui; Dawn Chong; Trang VoPham; Jeffrey A Meyerhardt; Deliang Wen; Edward L Giovannucci; Andrew T Chan; Xuehong Zhang Journal: Hepatology Date: 2019-03-05 Impact factor: 17.425
Authors: Nancy López-Olmedo; Barry M Popkin; Penny Gordon-Larsen; Lindsey Smith Taillie Journal: Public Health Nutr Date: 2019-07-08 Impact factor: 4.022
Authors: Amanda M Fretts; Fumiaki Imamura; Matti Marklund; Renata Micha; Jason H Y Wu; Rachel A Murphy; Kuo-Liong Chien; Barbara McKnight; Nathan Tintle; Nita G Forouhi; Waqas T Qureshi; Jyrki K Virtanen; Kerry Wong; Alexis C Wood; Maria Lankinen; Kalina Rajaobelina; Tamara B Harris; Luc Djoussé; Bill Harris; Nick J Wareham; Lyn M Steffen; Markku Laakso; Jenna Veenstra; Cécilia Samieri; Ingeborg A Brouwer; Chaoyu Ian Yu; Albert Koulman; Brian T Steffen; Catherine Helmer; Nona Sotoodehnia; David Siscovick; Vilmundur Gudnason; Lynne Wagenknecht; Sari Voutilainen; Michael Y Tsai; Matti Uusitupa; Anya Kalsbeek; Claudine Berr; Dariush Mozaffarian; Rozenn N Lemaitre Journal: Am J Clin Nutr Date: 2019-04-01 Impact factor: 7.045
Authors: Ge Li; Ling Zhong; Lanwen Han; Yonghui Wang; Bo Li; Dongmei Wang; Yanglu Zhao; Yu Li; Qian Zhang; Lu Qi; John R Speakman; Steven M Willi; Ming Li; Shan Gao Journal: Int J Obes (Lond) Date: 2021-10-29 Impact factor: 5.551
Authors: Guo-Chong Chen; Woon-Puay Koh; Nithya Neelakantan; Jian-Min Yuan; Li-Qiang Qin; Rob M van Dam Journal: Am J Epidemiol Date: 2018-12-01 Impact factor: 4.897
Authors: Wanshui Yang; Jing Sui; Longgang Zhao; Yanan Ma; Fred K Tabung; Tracey G Simon; Dong Hoon Lee; Xufen Zeng; Long H Nguyen; Jeffrey A Meyerhardt; Andrew T Chan; Edward L Giovannucci; Xuehong Zhang Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-01-29 Impact factor: 4.090